Erik Ostrowski Avrobio, Inc. (AVRO) insider trading activity

AVRO Quotes by TradingView

Erik Ostrowski is Interim CEO, President and CFO of AVROBIO, Inc.. Currently has a direct ownership of 29,285 shares of AVRO, which is worth approximately $0. The most recent transaction as insider was on Feb 05, 2024, when has been sold 13,099 shares (Common Stock) at a price of $1.2 per share, resulting in proceeds of $15,718. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.3K
0% 3M change
n/a 12M change
Total Value Held $0

Erik Ostrowski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 05 2024
SELL
Payment of exercise price or tax liability
$15,718 $1.2 p/Share
13,099 Reduced 30.91%
29,285 Common Stock
Feb 01 2024
BUY
Exercise of conversion of derivative security
-
40,084 Added 48.61%
42,384 Common Stock

Also insider at

AKBA
Akebia Therapeutics, Inc. Healthcare
SVP, CFO, CBO & Treasurer
EO

Erik Ostrowski

Interim CEO, President and CFO
Cambridge, MA

Track Institutional and Insider Activities on AVRO

Follow AVROBIO, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVRO shares.

Notify only if

Insider Trading

Get notified when an Avrobio, Inc. insider buys or sells AVRO shares.

Notify only if

News

Receive news related to AVROBIO, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVRO